2018 Guidelines of the Taiwan Society of Cardiology, Taiwan Society of Emergency Medicine and Taiwan Society of Cardiovascular Interventions for the management of non ST-segment elevation acute coronary syndrome

The Writing Group of 2018 Taiwan Guidelines for the Management of Non ST-segment Elevation Acute Coronary Syndrome

研究成果: 雜誌貢獻文章

8 引文 (Scopus)

摘要

In Taiwan, the incidence of non-ST segment elevation acute coronary syndrome (NSTE-ACS) continues to increase in recent years. The purpose of this guideline is to help health care professionals in Taiwan to use adequate tests and treatments for management of NSTE-ACS. For rapid diagnosis, in addition to history and physical examination, 0/3 h rapid diagnosis protocol with high sensitivity cardiac troponin assay is recommended in this guideline. Dual antiplatelet and anticoagulation therapies are important parts in the initial treatment. Risk stratification should be performed to identify high risk patients for early coronary angiography. Through evaluation of the coronary anatomy and other clinical factors, the decision for coronary revascularization, either by percutaneous coronary intervention or coronary artery bypass grafting, should be decided by the heart team. The duration of dual antiplatelet therapy should be given for at least 12 months after discharge. Other secondary preventive medications are also recommended for long term use.
原文英語
頁(從 - 到)766-790
頁數25
期刊Journal of the Formosan Medical Association
117
發行號9
DOIs
出版狀態已發佈 - 九月 1 2018

指紋

Emergency Medicine
Acute Coronary Syndrome
Cardiology
Taiwan
Guidelines
Troponin
Percutaneous Coronary Intervention
Therapeutics
Coronary Angiography
Coronary Artery Bypass
Physical Examination
Anatomy
History
Delivery of Health Care
Incidence

ASJC Scopus subject areas

  • Medicine(all)

引用此文

2018 Guidelines of the Taiwan Society of Cardiology, Taiwan Society of Emergency Medicine and Taiwan Society of Cardiovascular Interventions for the management of non ST-segment elevation acute coronary syndrome. / The Writing Group of 2018 Taiwan Guidelines for the Management of Non ST-segment Elevation Acute Coronary Syndrome.

於: Journal of the Formosan Medical Association, 卷 117, 編號 9, 01.09.2018, p. 766-790.

研究成果: 雜誌貢獻文章

@article{592ca47bc8604a0c873ecf077524148e,
title = "2018 Guidelines of the Taiwan Society of Cardiology, Taiwan Society of Emergency Medicine and Taiwan Society of Cardiovascular Interventions for the management of non ST-segment elevation acute coronary syndrome",
abstract = "In Taiwan, the incidence of non-ST segment elevation acute coronary syndrome (NSTE-ACS) continues to increase in recent years. The purpose of this guideline is to help health care professionals in Taiwan to use adequate tests and treatments for management of NSTE-ACS. For rapid diagnosis, in addition to history and physical examination, 0/3 h rapid diagnosis protocol with high sensitivity cardiac troponin assay is recommended in this guideline. Dual antiplatelet and anticoagulation therapies are important parts in the initial treatment. Risk stratification should be performed to identify high risk patients for early coronary angiography. Through evaluation of the coronary anatomy and other clinical factors, the decision for coronary revascularization, either by percutaneous coronary intervention or coronary artery bypass grafting, should be decided by the heart team. The duration of dual antiplatelet therapy should be given for at least 12 months after discharge. Other secondary preventive medications are also recommended for long term use.",
keywords = "Acute coronary syndrome, Guideline, Taiwan",
author = "{The Writing Group of 2018 Taiwan Guidelines for the Management of Non ST-segment Elevation Acute Coronary Syndrome} and Li, {Yi Heng} and Wang, {Yu Chen} and Wang, {Yi Chih} and Liu, {Ju Chi} and Lee, {Cheng Han} and Chen, {Chun Chi} and Hsieh, {I. Chang} and Kuo, {Feng You} and Huang, {Wei Chun} and Sung, {Shih Hsien} and Chiu, {Chiung Zuan} and Hsu, {Jung Cheng} and Jen, {Shu Long} and Hwang, {Juey Jen} and Lin, {Jiunn Lee}",
year = "2018",
month = "9",
day = "1",
doi = "10.1016/j.jfma.2018.06.002",
language = "English",
volume = "117",
pages = "766--790",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
publisher = "Elsevier Science Publishers B.V.",
number = "9",

}

TY - JOUR

T1 - 2018 Guidelines of the Taiwan Society of Cardiology, Taiwan Society of Emergency Medicine and Taiwan Society of Cardiovascular Interventions for the management of non ST-segment elevation acute coronary syndrome

AU - The Writing Group of 2018 Taiwan Guidelines for the Management of Non ST-segment Elevation Acute Coronary Syndrome

AU - Li, Yi Heng

AU - Wang, Yu Chen

AU - Wang, Yi Chih

AU - Liu, Ju Chi

AU - Lee, Cheng Han

AU - Chen, Chun Chi

AU - Hsieh, I. Chang

AU - Kuo, Feng You

AU - Huang, Wei Chun

AU - Sung, Shih Hsien

AU - Chiu, Chiung Zuan

AU - Hsu, Jung Cheng

AU - Jen, Shu Long

AU - Hwang, Juey Jen

AU - Lin, Jiunn Lee

PY - 2018/9/1

Y1 - 2018/9/1

N2 - In Taiwan, the incidence of non-ST segment elevation acute coronary syndrome (NSTE-ACS) continues to increase in recent years. The purpose of this guideline is to help health care professionals in Taiwan to use adequate tests and treatments for management of NSTE-ACS. For rapid diagnosis, in addition to history and physical examination, 0/3 h rapid diagnosis protocol with high sensitivity cardiac troponin assay is recommended in this guideline. Dual antiplatelet and anticoagulation therapies are important parts in the initial treatment. Risk stratification should be performed to identify high risk patients for early coronary angiography. Through evaluation of the coronary anatomy and other clinical factors, the decision for coronary revascularization, either by percutaneous coronary intervention or coronary artery bypass grafting, should be decided by the heart team. The duration of dual antiplatelet therapy should be given for at least 12 months after discharge. Other secondary preventive medications are also recommended for long term use.

AB - In Taiwan, the incidence of non-ST segment elevation acute coronary syndrome (NSTE-ACS) continues to increase in recent years. The purpose of this guideline is to help health care professionals in Taiwan to use adequate tests and treatments for management of NSTE-ACS. For rapid diagnosis, in addition to history and physical examination, 0/3 h rapid diagnosis protocol with high sensitivity cardiac troponin assay is recommended in this guideline. Dual antiplatelet and anticoagulation therapies are important parts in the initial treatment. Risk stratification should be performed to identify high risk patients for early coronary angiography. Through evaluation of the coronary anatomy and other clinical factors, the decision for coronary revascularization, either by percutaneous coronary intervention or coronary artery bypass grafting, should be decided by the heart team. The duration of dual antiplatelet therapy should be given for at least 12 months after discharge. Other secondary preventive medications are also recommended for long term use.

KW - Acute coronary syndrome

KW - Guideline

KW - Taiwan

UR - http://www.scopus.com/inward/record.url?scp=85049739967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049739967&partnerID=8YFLogxK

UR - http://www.mendeley.com/research/2018-guidelines-taiwan-society-cardiology-taiwan-society-emergency-medicine-taiwan-society-cardiovas-1

U2 - 10.1016/j.jfma.2018.06.002

DO - 10.1016/j.jfma.2018.06.002

M3 - Article

C2 - 30017533

AN - SCOPUS:85049739967

VL - 117

SP - 766

EP - 790

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

SN - 0929-6646

IS - 9

ER -